UnitedHealth Group delivered strong Q1 results with 14% revenue growth and an increased EPS outlook, driven by robust performance in Optum and UnitedHealthcare segments. Management's positive tone on strategic initiatives and their ability to mitigate inflationary pressures support confidence in continued growth. These factors are likely to positively influence the stock in the short term.

[1]